Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
Alexander M. Horspool, Chengjin Ye, Ting Y. Wong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai, Jasper Fuk‐Woo Chan, Terrence Tsz‐Tai Yuen, et al.
EBioMedicine (2021) Vol. 73, pp. 103643-103643
Open Access | Times Cited: 171
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
Lok-Yin Roy Wong, Stanley Perlman
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 47-56
Open Access | Times Cited: 164
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
Jiejie Geng, Liang Chen, Yufeng Yuan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
COVID-19 Mechanisms in the Human Body—What We Know So Far
Ashutosh Kumar, Ravi Kant Narayan, Pranav Prasoon, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 64
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Emerging SARS‐CoV‐2 variants can potentially break set epidemiological barriers in COVID‐19
Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1300-1314
Open Access | Times Cited: 43
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 40
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges
Nazia Thakur, Giulia Gallo, Joseph Newman, et al.
Journal of General Virology (2022) Vol. 103, Iss. 4
Open Access | Times Cited: 23
Animal models for SARS‐CoV‐2 infection and pathology
Zhenfei Bi, Weiqi Hong, H. J. Yang, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 548-568
Open Access | Times Cited: 30
Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 117-117
Open Access | Times Cited: 28
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8
Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, Ralf Duerr, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo
Kevin Chiem, Desarey Morales Vasquez, Jesus A. Silvas, et al.
Journal of Virology (2021) Vol. 95, Iss. 22
Open Access | Times Cited: 18
Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19
Ashutosh Kumar, Rakesh Parashar, Muneeb A. Faiq, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 9
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Sergio A. Rodriguez‐Aponte, Neil C. Dalvie, Ting Y. Wong, et al.
Vaccine (2022) Vol. 41, Iss. 5, pp. 1108-1118
Open Access | Times Cited: 6
Early circulating strain of SARS-CoV-2 causes severe pneumonia distinct from that caused by variants of concern
Yusuke Matsumoto, Fumihiko Yasui, Akinori Endo, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
Charlie Fricke, Florian Pfaff, Lorenz Ulrich, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 12
Open Access | Times Cited: 2
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8
Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, Ralf Duerr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Generation of a SARS-CoV-2-susceptible mouse model using adenovirus vector expressing human angiotensin-converting enzyme 2 driven by an elongation factor 1α promoter with leftward orientation
Yusuke Matsumoto, Tomoko Honda, Fumihiko Yasui, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
SARS-CoV-2 variants of concern Alpha, Beta, Gamma and Delta have extended ACE2 receptor host-ranges
Nazia Thakur, Giulia Gallo, Joseph Newman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Gene delivery of a single,structurally engineered Coronavirus vaccine antigen elicits SARS-CoV-2 Omicron and pan-Sarbecovirus neutralisation
Jonathan L. Heeney, Sneha Vishwanath, George Carnell, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Advances in Modelling COVID-19 in Animals
Petr Nickl, Miles Joseph Raishbrook, Linn Amanda Syding, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 1
Assessment of Jordanian health care professionals’ perception towards new COVID-19 variants of concern
Hana M. Sawan, Shatha M. Al Omari, Fares Albahar, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0265797-e0265797
Open Access | Times Cited: 1
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo
Kevin Chiem, Desarey Morales Vasquez, Jesus A. Silvas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 1
Early circulating strain of SARS-CoV-2 causes severe pneumonia distinct from that caused by variants of concern in mice transduced with an adenoviral vector expressing human ACE2
Yusuke Matsumoto, Fumihiko Yasui, Akinori Endo, et al.
Research Square (Research Square) (2022)
Open Access
Utilizing the K18-hACE2 mouse model to develop protective COVID-19 vaccines
Ting Y. Wong
(2022)
Open Access
Page 1 - Next Page

Scroll to top